Model
Edge
4D Molecular Therapeutics
0001881504
Filing Type
4
Filing Date
10/2/2023
Updated
10/3/23, 10:17 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership